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In countries where prenatal care äs well äs care
of the parturient is well organised, placental
dysfunction is nowadays one of the most
frequent causes of the perinatal mortality in the
last trimester of pregnancy. Timely (i. e. antenatal)
diagnosis of this condition is thus one of the
basic requirements for the prevention not only
of perinatal mortality but also of morbidity. The
diagnositc importance of estriol in the urine of
pregnant women in cases of fetal danger has
been confirmed in the literature of the last
decade. Numerous authors confirm however,
that the daily variance of estriol clearance
— 20—50% — is a drawback which, in part,
lessens the reliability of this method in cases of
low or gradually decreasing values. A new
functional element, rendering the diagnostic
importance of estriol level mofe precise, is
achieved through the administration to the
mother of dehydroepiandrosterone-sulphate
(DHEA-S) which is metabolized by the placenta
and the fetus to estriol. The functional activity of
the whole fetoplacental unit is judged either from
the increased amount of excreted estriol in
24 hours äs suggested by LAURITZEN [2], or
from the degradation rate of the administered
DHEA-S which v. D. CRABBEN [1] determines
by measuring the estriol excretion peak in urine
samples withdrawn every two hours.
1. Methods
The above mentioned DHEA-S test was modified so äs to
a) maintain the diagnostic significance of the values of
estriol excreted (in mg/24 hours), uninfluenced by the
administration of DHEA-S,
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b) demonstrate the diagnostic significance of the two new
elements, i. e. the rate and the intensity of the degradation
of the administered DHEA-S to estriol,
c) eliminate the unfavorable effect of day-variation of
estriol clearance (in mg/24 hrs.) on the reliability of the
method.
The test is performed and evaluated in the following way
(Fig. 1). From the first two two-hourly urine samples
withdrawn before DHEA-S administration (i. e. 6—8 a.m.
and 8—10 a. m.), the initial estriol value is calculated äs
the first parameter (a). In the f ollowing four two-hourly
samples (10 a. m.—6 a. m.), after 30 mg DHEA-S I. V.
administration (at 10 a. m.), a further 3 parameters are
evaluated: The time taken to reach the excretion peak (b),
the height of the peak (c) and the total amount of ex-
creted estriol in the four samples after DHEA-S admin-
istration (d). In order to eliminate the effect of diurnal
Variation of estriol urine clearance, the initial value is
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Fig. 1. Evaluation of the 4 parameters of the DHEA-S test:
a) initial value (arithmetical means of two 2 hours urine
samples before DHEA-S administration) in mg, b) time of
attaining the excretion peak after DHEA-S administration
(in hours), c) magnitude of excretion peak in mg (cal-
culated from the initial value increased by 20%), d) total
amount o£ excreted estriol within an 8 hour period in mg
(calculated from the initial value increased by 20%).
calculated thes  arithmetic mean frora the first two
samples; the further 3 parameters are checked against this
initial value to which 20% has been added. The 20% is
added since STEMBERA and HERZMANN [3] found that the
95% confidence limit for two-hourly day-variation cor-
responded to the increase of the initial value by 20%; this
was noted from the study of 20 pregnant women in whom
estriol clearance was followed in two-hourly urine samples
without DHEA-S administration.
The clinical condition of the newborn imme-
diately after delivery was employed s the ob-
jective criterion for the evaluation of the
results of the DHEA-S test. All of the following
cases could be divided into 4 groups accordingly:
1. Completely healthy newborns 2. Newborns
with postnatal depression (APGAR score 7 and
less points l minute after delivery) 3. Small-for-
date newborns (according to Lubchenko) 4.
Stillbirths.
If the test had been repeated several times on the
same woman the one which was last performed
within l—5 days prior to delivery was used for
the comparison with the clinical state of the
newborn. The estimation of estriol was performed
according to ITTRICH. The recovery-rate in our
laboratory is 97,45% ± 1.75%.
2. Results
In the preceding phase of this study STEMBERA
and HERZMANN [3] found in 48 pregnant women
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quantificated according to placental function.
Each of the 4 above-mentioned parameters of
the DHEA-S test (a—d) was subdivided into
several groups according to significance and
for each of these subdivisions the respective
number of points was stated (Tab. I). Their
sum indicates the functional activity of the
fetoplacental unit; the value of the index did
indeed correlate well with the clinical con-
dition of the newborn. In 16 out of 18 mothers
whose newborns showed some deviation from
the norm a low value of the test was found.
This was why, in the next phase of the study, the
authors attempted to determine, by means of the
DHEA-S test, a more detailed prediction of
fetal state using a small Computer. Each of the
four parameters f ound (a—d) was classified intp
6 groups.„and,-£rom the values obtained, a para-
meter diagnosis matrix was set up in 80 cases
in which 100 examinations were performed.
From the set up matrix, the probability of the
individual diagnosis for each case was cal-
culated. The calculations were performed using
a small CLARY DE-600 Computer.
The Output of the Computer (Fig.2) consists of
4 sets of figures for each case, characterizing 4
possible clinical predictions. The value of the
figure in a group determines the probability that
the given case falls within that group; e. g.,
the higher the digit in the first column, the
higher the probability of a healthy newborn;
on the other hand, the higher the digit in the
last column, the higher the possibility of a
stillbirth.
The comparison of the prognoses, thus found,
with the actual clinical state of the newborn
revealed, in each individual case (Fig. 3A), that
in two thirds of all healthy ftewborns the
prodiction was correct with a probability
higher thän 70%. Such a high probability of a
healthy newborn was not found in a single case
in the other 3 groups of newborns; all cases in the
last two groups (small-for-dates and stillbirths)
showed only a very low probability (i. e. 20% or
less) of becoming healthy newborns. Such a low
probability was also found in two thirds of the
cases with postnatal depression, yet only in 3





















Fig. 2. Original Computer Output determining one of the
four possibilities of fetal development for each case; for
classifying into one of the four groups, the highest of the
4 digits in each case is decisive (e. g. in the first 12 cases the
diagnosis "healthy newborn" was stated, whereas the 13th
case was diagnosed äs a "newborn with a decreased
APGAR score").
A.Probabi lhy of h e a l t h y felus B.Probability of st i l lbir th
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Fig. 3. Comparison of the cömputed prognoses of fetal
development with the actual clinical state of the newborn:
A) Percentage probability of a healthy newborn in all
80 cases, divided into four groups according to the acutal
clinical state after delivery, B) Percentage probability of a
stillbirth in 27 cases in whom the expectation of there
being a healthy fetus was very low (see Fig. 3A — cases
below the dashed line under 20%).
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A further diflerentiation of the cases with a very
low probability of healthy development can be
performed by determining the prediction of
stillbirths (Fig. 3B), In this differentiation both
cases in the stillbirth group show a high pro-
bability of stillbirth, whereas all 3 cases of
healthy newborns (first group) show zero
probability of stillbirth. When in 5 cases of the
remaining two groups a high probability of
stillbirth was apparent, pregnancy, in 4 out of
these five cases, was terminated by elective
Caesarean section, äs a preventive measure,
because of the indication of danger to the fetus.
In the same way we can perform further dif-
ferentiation of each of the remaining less
serious cases (in which our prediction of the
birth of a healthy newborn was only between
20—70%), for example by determining the
probability of neonatal depression.
The prediction of fetal development, according
to the principle of conditioned probability, was
used in a further 33 cases of high risk pregnancy
in the following phase of the study. In 84% of
these cases, the prediction of fetal development
correlated with the actual clinical condition
of the newborn. The calculation was carried
out on the basis of the above matrix set up from
the examination of 80 cases. The possible com-
binations offered by the 4 parameters divided
into 6 groups are nevertheless many times
greater; this is why the greater the number of
cases in the matrix the greater the reliability
of predicting fetal development in high risk
pregnancies.
3. Discussion
The setting up of a parameter-diagnosis matrix
and the comparison of the prediction with the
actual state of the fetus is based on the pre-
sumption of a "fix" clinical diagnosis, i. e.
the neonatal state, resulting from a good feto-
placental function or dysfunction. However,
with this "fix" diagnosis further factors are
involved; these are capable of influencing the
prediction of fetal state both favorably or un-
favorably:
a) temporary neonatal depression of the new-
born originating in the last phase of delivery
due to the umbilical cord being tightly wound
around the fetal neck;
b) temporary neonatal depression caused by
narcotics used in the surgical termination of
labor;
c) in severe placental insufficiency it is possible,
by premature termination of pregnancy (i. e. by
induction of labor or by elective Caesarean
section), to avoid severe progressive fetal dystro-
phia or stillbirth. However, waiting for several
days or weeks for spontaneous beginning of
labor would probably be even more deleterious
for the fetus than suggested by the calculation.
For the evalutation of the DHEA-S test the last
test was always carried out within l—5 days
before delivery, but, owing to Variation in the
gestational period, this was anywhere between
the 36th—43rd week of pregnancy. The time
factor, therefore, undoubtedly also very im-
portant in placental physiology, has not so far
been considered in the evaluation of the
DHEA-S test.
Although the DHEA-S test was used in all high
risk pregnancies, it nevertheless seems very
probable that placental dysfunction (cf. diabetes,
toxemia, Rh-isoimmunisation, overdue birth) was
not the main cause of danger in all of them.
The two methods of evaluating the DHEA-S
test, i. e. the scoring System expressing the
degree of placental dysfunction (Tab. I) and the
prediction of the fetal state using conditioned pro-
bability, represent two different approaches for
the assessment of danger to the fetus. In the
scoring System we merely try to quantify the
degree of placental dysfunction. In predicting
the fetal state we nevertheless try, besides
determining the limit between the physiological
and pathological state, to differentiate the
consequence of placental dysfunction at the
same time. Although the results of this study
seem to indicate that the prediction of intrauterine
fetal development using a small-size Computer
could render effective help for obstetrical practice,
two basic facts should always be kept in mind,
viz:
1. The DHEA-S test is only one of the many
methods of determining fetal danger due to
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placental dysfunction. However, äs the fetus is 2. A Computer can nevef replace a physician but
threatened in many difFerent ways, we cannot can help him efFectively. In the final analysis it is
expect one single method to diagnose reliably the physician who must take the overall respon-
every intrauterine fetal danger. sibility and make the diagnosis.
Summary
Four parameters o£ DHEA-S were evaluated: a) initial
value, b) time of peak excretion, c) height of the peak,
d) total amount of excreted estriol after DHEA-S
administration (Fig. 1). The last three data were evaluated
by checking them against the initial value increased by
20%. In this way the diagnostic significance of the excreted
estriol, uninfluenced by DHEA-S is maintained utilizing
at the same time both functional elements, i. e. the rate äs
well äs the intensity of DHEA-S degradation to estriol, in
which the metabolism of both the placenta and the fetus
participates. In this way we simultaneously exclude
the unfavorable effect of day variance of estriol ex-
' cretion. The clinical condition of the newborn is
classified into 4 groups according to degree of severity,
viz.: healthy newborns, newborns with postnatal
depression (decreased APGAR score), small-for-dates and
stillbirths.
Quantification of the DHEA-S test was performed using
48 women, comparing the clinical state of the newborn
with the above-mentioned four test parameters. For each
of the parameters the respective number of points was
calculated (Fig. 3). Their sum expressed the functional
activity of the fetoplacental unit, which correläted well
with the clinical state of the newborn. For determining
a more detailed prediction of the fetal state the above four
parameters were subdivided into six classes according to
degree of severity; thus from 100 examinations a parameter-
diagnosis matrix was set up. From the set up matrix, the
conditioned probability of the individual prediction in
each case was calculated using a small Computer (Fig. 2).
In a further 33 cases of high risk pregnancy the prediction
thus determined, correläted in 84 percent with the
actual clinical state of the newborn. It will be possible
to increase the reliability percentage of the DHEA-S test
by Supplement ing the matrix with further cases. The
prediction is, however, distorted by various factors
affecting the clinical condition of the newborn.
Keywords: Computers, diagnosis diferential, estriol, fetus, placental hormones, pregnancy complications, prenatale care.
Zusammenfassung
Modifizierter DHEA-S-Test als Index für die feto-
plazentare Insuffizienz
Vier Parameter unter DHEA-S wurden ausgewertet:
a) der Initialwert, b) die Zeit der maximalen Ausschei-
dung, c) die Höhe der maximalen Ausscheidung und
d) die Gesamtmenge des ausgeschiedenen Östriols
nach Gaben von DHEA-S. Die letzten drei' Kriterien
wurden ausgewertet durch die Gegenüberstellung mit dem
um 20% erhöhten Initialwert (Fig. 1). Auf diese Weise
bleibt die diagnostische Signifikanz des ausgeschiedenen
Östriols aufrechterhalten ohne störenden Einfluß von
DHEA-S unter gleichzeitiger Berücksichtigung funk-
tioneller Gesichtspunkte, nämlich der Rate und Intensität
des Abbaus von DHEA-S zu Östriol, woran der Stoff-
wechsel der Plazenta und des Feten in gleicher Weise
beteiligt ist. So schlössen wir gleichzeitig auch den un-
günstigen Effekt der Tagungsschwankungen in der
Östriolausscheidung aus. Der klinische Zustand der
Neugeborenen wird in 4 Gruppen eingeteilt entsprechend
dem Schweregrad, nämlich: Gesundes Neugeborenes,
postnataler Depressionszustand (herabgesetzter APGAR-
Score), Dysmaturität und Totgeburt.
Eine quantitative Auswertung des DHEA-S Testes wurde
bei 48 Frauen durchgeführt, indem der klinische Zu-
stand des Neugeborenen mit den oben angegebenen
4 Parametern verglichen wurde (Fig. 3). Für jeden der
Parameter wurde eine entsprechende Punktzahl ermittelt.
Die Gesamtzahl der Punkte war Ausdruck für die funk-
tioneile Aktivität der feto-plazentaren Einheit, was gut
mit dem klinischen Zustand des Neugeborenen korre-
lierte. Um eine mehr detaillierte Prognose der fetalen Ent-
wicklung zu ermitteln, wurden die oben genannten 4
Parameter in 6 Stufen aufgeteilt, entsprechend dem
Schweregrad, und aus 100 Untersuchungen eine Matrix
mit den diagnostischen Parametern aufgestellt. Mit Hilfe
dieser Matrix wurde unter Verwendung eines Klein-
computers die Wahrscheinlichkeit der individuellen
Prognose eines jeden Falles ermittelt (Fig. 2). In
weiteren 33 Fällen von Risikoschwangerschaften entsprach
die so ermittelte Prognose in 84% dem echten kli-
nischen Zustand des Neugeborenen. Es wird möglich
sein, die prozentuale Zuverlässigkeit des DHEA-S Testes
weiter zu verbessern, indem man die Matrix durch weitere
Fälle ergänzt. Daneben wird aber die ermittelte Prognose
in ungünstiger Weise durch verschiedene Faktoren be-
einflußt, die den klinischen Zustand des Neugeborenen
betreffen.
Schlüsselwörter: Computer, Differentialdiagnose, Östriol, Fetus, Plazentarhormone, Schwangerschaftskomplikationen,
pränatale Betreuung.
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Resume
Index d'insuffisance foeto-placentaire avec les quatre paramfctres sus-d6crits. A chaque parametre
Quatre mesures ont 6te faites pour la DHEA-S: a) La on a attribue un nombre correspondant de points. Leur
valeur initiale, b) le moment du pic d'excr£tion, c) la somme exprimant Factivite fonctionelle de l'unite
hauteut du pic, d) la quantite totale d'oestriols ex- foeto-placentaire, et eile prosentait une bonne correlation
cret£s apres administration de DHEA-S. On a 6valu6 les avec l'itat clinique du nouveau-ηέ.
trois dernieres donndes en les contr lant par rapport a Pour otablir un pronostic plus precis du daveloppement
la valeur initiale augmentoe de 20%. De cette fagon on foetal les quatre parametres ont έίέ ropartis en six classes
conserve s valeur diagnostique a l'excrotion d'oestriols non selon la gravite de l'etat foetal, et pour 100 examens une
modifiee par la DHEA-S, en utilisant en m£me temps les etude de corrolation parametre-diagnostic a ete roalisee. A
deux olements fonctionnels, c'est- -dire la vitesse ainsi que partir de cette matrice, la probabilite de chaque pro-
Pintensito de la degradation de la DHEA-S en oestriol, nostic particulier £tait calculee a l'aide d'un petit
dans lequel entrent en jeu la placenta et le foetus. De cette calculateur. Pour les 33 cas suivants de grossesse a haut
facon, nous avons exclu en meme temps reffet d6- risque le pronostic determine de cette fa$on donnait une
favorable des variations d'excr6tion de Toestriol au bonne correlation avec l'etat r6el du nouveau-ne dans
cours du nyctem&ce. L'etat clinique du nouveau-ne a 84%des cas. II sera possible d'amoliorer le pourcentage de
ete classe en 4 groupes, c'est- -dire: nouveau-ne fiabilito du test a la DHEA-S en completant la matrice
vigoureux, avec dopression post-natale (score d'AroAR avec d'autres cas. Par ailleurs, le pronostic ainsi determine
bas), hypotrophique et prlmature. est fausso par di erents facteurs afFectant l'dtat clinique du
On a pratiqud la mesure quantitative de la DHEA-S chez nouveau-ηέ.
48 femmes en comparant Petat clinique du nouveau-ηέ
Mots-cles: Ordinateurs, diagnostic diίΓέrentiel, oestriol, foetus, hormones placentaires, complications de la grossesse,
soins prenatals.
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